Related Articles
Guillain‑Barre syndrome induced by pembrolizumab and sunitinib: A case report
Cytokine release syndrome induced by immune checkpoint inhibitor treatment for uterine cervical cancer recurrence: A case report
Discontinuation of anti‑programmed cell death protein 1 immune checkpoint inhibition after complete remission in head and neck squamous cell carcinoma: A case report and literature review
Sorafenib-induced reversible posterior leukoencephalopathy in patients with renal cell carcinoma: A report of two cases
Complete response to tremelimumab plus durvalumab treatment in hepatocellular carcinoma with a bile duct tumor thrombus: <br />A case report